1. The Effects of a Carbohydrate Hydrogel System for the Delivery of Bicarbonate Mini-Tablets on Acid–Base Buffering and Gastrointestinal Symptoms in Resting Well-trained Male Cyclists.
- Author
-
Gough, Lewis A. and Sparks, S. Andy
- Subjects
CHLORIDES analysis ,ELECTROLYTE analysis ,DIARRHEA prevention ,DRUG delivery systems ,SODIUM bicarbonate ,DRUG tablets ,ANALYSIS of variance ,OXYGEN consumption ,SODIUM ,GASTROINTESTINAL diseases ,PHYSICAL training & conditioning ,VISUAL analog scale ,COLIC ,POTASSIUM ,MANN Whitney U Test ,CYCLING ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,CARBOHYDRATES ,PHARMACEUTICAL gels ,BICARBONATE ions ,BLIND experiment ,DESCRIPTIVE statistics ,RESEARCH funding ,STATISTICAL sampling ,CROSSOVER trials ,BODY mass index ,CALCIUM ,DATA analysis software ,ACID-base equilibrium ,BOWEL & bladder training ,SYMPTOMS - Abstract
Background: A new commercially available sodium bicarbonate (SB) supplement claims to limit gastrointestinal (GI) discomfort and increase extracellular buffering capacity. To date, no available data exists to substantiate such claims. Therefore, the aim of this study was to measure blood acid–base balance and GI discomfort responses following the ingestion of SB using the novel "Bicarb System" (M-SB). Twelve well-trained male cyclists completed this randomised crossover designed study. Maximal oxygen consumption was determined in visit one, whilst during visits two and three participants ingested 0.3 g∙kg
−1 BM SB using M-SB (Maurten, Sweden) or vegetarian capsules (C-SB) in a randomised order. Finger prick capillary blood samples were measured every 30 min for pH, bicarbonate (HCO3 − ), and electrolytes (potassium, chloride, calcium, and sodium), for 300 min. Visual analogue scales (VAS) were used to assess GI symptoms using the same time intervals. Results: Peak HCO3 − was 0.95 mmol∙L−1 greater following M-SB (p = 0.023, g = 0.61), with time to peak HCO3 − achieved 38.2 min earlier (117 ± 37 vs. 156 ± 36 min; p = 0.026, r = 0.67) and remained elevated for longer (p = 0.043, g = 0.51). No differences were observed for any electrolytes between the conditions. Aggregated GI discomfort was reduced by 79 AU following M-SB (p < 0.001, g = 1.11), with M-SB reducing stomach cramps, bowel urgency, diarrhoea, belching, and stomach-ache compared to C-SB. Conclusions: This is the first study to report that M-SB can increase buffering capacity and reduce GI discomfort. This presents a major potential benefit for athletes considering SB as an ergogenic supplement as GI discomfort is almost eliminated. Future research should determine if M-SB is performance enhancing. Key Points: The novel 'Bicarb System' (M-SB) reduced, and almost eliminated the gastrointestinal (GI) discomfort compared to vegetarian capsules (C-SB). The changes in acid-base balance following ingestion of M-SB were significantly greater compared to C-SB. It is unkown if this would translate to increased performance benefits, however, and the next step therefore is to determine the performance responses from M-SB. The increase in HCO3 − was sustained >5 mmol L−1 HCO3 − for longer with M-SB ingestion versus C-SB. This might suggest there is an "ergogenic window", and ingestion timing could therefore be flexible prior to exercise. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF